A recently amended regulatory filing with the Securities & Exchange Commission shows that Cardiovascular Systems (NASDAQ:CSII) has raised $7.5 million in debt, a portion of which has been converted to stock. The filing has its roots in a 2010 debt agreement with Partners for Growth III through which the Minnesota company raised a total of […]
Cardiovascular Systems Inc. named Kevin Kenny to the newly created position of executive vice president of sales and marketing. The New Brighton, Minnesota-based medical device company, which develops and sells solutions for treating vascular and coronary disease, said that Kenny would oversee all sales and marketing functions. Previously, Kenny held several positions at Medtronic, most […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Cardiovascular Systems Inc. recently announced that it’s started a limited-market release of its Stealth 360° Orbital PAD System, the latest in the company’s line of catheter-based systems that rub away plaque in clogged arteries in the pelvis or leg. St. Paul, Minnesota-based CSI (NASDAQ:CSII) claims the Stealth 360° has a simpler, more user-friendly design than […]
Ernie Andberg has a little more free time on his hands these days. The long-time “emerging medical device companies” equity analyst for Feltl & Co. in Minneapolis has not seen a lot of companies emerging lately. In fact, they’ve been disappearing all together. Case in point: Medtronic Inc.’s (NYSE: MDT) deal last week to acquire […]